Newsfeeds - Spark Newswire

4 minute read

48 Biggest Movers From Friday

Today, 5:03 AM

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.

AKYA

1 minute read

News

Why BeiGene Shares Are Rising

By Henry Khederian

Today, 5:03 AM

Beigene Ltd (NASDAQ: BGNE) shares are trading higher by 3.8% at $400 after the company announced it received a positive CHMP opinion for BRUKINSA for the treatment of adults with Waldenström's macroglobulinemia.

BGNE

2 minute read

25 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 5:03 AM

Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 92.7% to $17.35 after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.

AUUD

2 minute read

Beigene Insider Trades $33.79 Million In Company Stock

By Benzinga Insights

Today, 5:03 AM

John Oyler, Chief Executive Officer at Beigene (NASDAQ:BGNE), made a large insider sell on September 15, according to a new SEC filing.

BGNE

2 minute read

15 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 5:03 AM

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading.

ABCL

1 minute read

Zymeworks’ Zanidatamab Aces Mid-Stage Esophageal Cancer Trial

By Vandana Singh

Today, 5:03 AM

At the European Society of Medical Oncology Congress 2021 (ESMO21), Zymeworks Inc (NYSE:ZYME) presented encouraging early data on…

BGNE

2 minute read

Notable Beigene Insider Makes $4.62 Million Sale

By Benzinga Insights

Today, 5:03 AM

Jane Huang, Cmo And Hematology at Beigene (NASDAQ:BGNE), made a large insider sell on September 13, according to a new SEC filing.

BGNE

5 minute read

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

By Shanthi Rexaline

Today, 5:03 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

ACHL

1 minute read

Leap Therapeutics Stock Is Moving Higher On Updated DKN-01 Combo Trial Data In Gastric Cancer

By Vandana Singh

Today, 5:03 AM

Leap Therapeutics Inc (NASDAQ:LPTX) announced updated data from the first-line cohort of the DisTinGuish Phase 2a trial evaluating DKN-01 combined with BeiGene…

BGNE

1 minute read

BeiGene’s Brukinsa Scores FDA Approval For Marginal Zone Lymphoma

By Vandana Singh

Today, 5:03 AM

The FDA has granted accelerated approval to BeiGene Ltd’s (NASDAQ:BGNE) Brukinsa (zanubrutinib) for relapsed or refractory (R/R) marginal zone lymphoma (MZL) who…

BGNE